Phase II study of neoadjuvant therapy with docetaxel, cisplatin, panitumumab, and radiation therapy followed by surgery in patients with locally advanced adenocarcinoma of the distal esophagus (ACOSOG Z4051).

Lockhart AC, Reed CE, Decker PA, Meyers BF, Ferguson MK, Oeltjen AR, Putnam JB, Cassivi SD, Montero AJ, Schefter TE, American College of Surgeons Oncology Group
Ann Oncol. 2014 25 (5): 1039-44

PMID: 24562448 · PMCID: PMC5808674 · DOI:10.1093/annonc/mdu091

MeSH Terms (20)

Adenocarcinoma Adult Aged Antibodies, Monoclonal Antineoplastic Combined Chemotherapy Protocols Chemoradiotherapy, Adjuvant Cisplatin Disease-Free Survival Docetaxel Esophageal Neoplasms Esophagogastric Junction Female Humans Kaplan-Meier Estimate Male Middle Aged Neoadjuvant Therapy Panitumumab Taxoids Treatment Outcome

Connections (1)

This publication is referenced by other Labnodes entities: